consider calcifediol when faster repletion or persistent SHPT is relevant), avoid mega-bolus dosing, and reserve active VDRAs for clear SHPT indications with careful calciumphosphatePTH monitoringnot as disease-modifying therapy in unselected CKD
Studies on the variability of glutathione S-transferase from research subjects [PMID: 7067148] Laboratory literature summary: Studies on the variability of glutathione S-transferase from research subjects erythrocytes
Optimizing bioavailability without compromising quality One of the main challenges when formulating glutathione is its sensitivity to digestive environment conditions
These genetic predispositions affect how your body's signaling pathways respond to GLP-1 agonists
GLP-1 Compounded Medications Targeted by Connecticut Attorney General On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications
A person can weigh less but still have a higher-than-ideal body-fat percentage if too much lean mass is lost